It binds to the GLP-1R, stimulating insulin secretion, suppressing glucagon release, delaying gastric emptying, and promoting satiety
Semaglutide: A Versatile Player Sema glutide has emerged as a dynamic contributor among GLP-1 agonists, receiving FDA approval for its role in managing type 2 diabetes, combating chronic kidney disease and aiding weight loss
GLP-1 improves mitochondrial function via regulation of autophagy, inhibits myocardial apoptosis, and optimizes cardiac energy metabolism [41, 42]
It just wasnt the outcome people were hoping for. UPDATE: November 27 9:10AM ET
Because subcutaneous tissue has fewer blood vessels than muscle, the drug is absorbed gradually, which helps reduce sharp peaks and gives a smoother, more sustained effect